Keywords
Immune systemImmunotherapyImmune checkpointImmunologyAntigenBlockadeBiologyCancer immunotherapyImmunityCytotoxic T cellPeripheral toleranceCollateral damageCancer researchAntibodyImmune toleranceReceptorIn vitro
Affiliated Institutions
Related Publications
Cancer immunotherapy using checkpoint blockade
The release of negative regulators of immune activation (immune checkpoints) that limit antitumor responses has resulted in unprecedented rates of long-lasting tumor responses i...
The biologic importance of tumor‐infiltrating lymphocytes
Detailed pathologic analysis has delineated a close association between intratumoral CD 8 + cytotoxic T cells and favorable clinical outcomes in diverse cancers. Conversely, the...
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Cancer treatment by immune checkpoint blockade (ICB) can bring long-lasting clinical benefits, but only a fraction of patients respond to treatment. To predict ICB response, we ...
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
The wide range of immune-related adverse effects associated with immune checkpoint blockade can complicate this effective therapy and limit its use in patients with cancer. This...
Publication Info
- Year
- 2012
- Type
- review
- Volume
- 12
- Issue
- 4
- Pages
- 252-264
- Citations
- 13276
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
13276
OpenAlex
Cite This
Drew M. Pardoll
(2012).
The blockade of immune checkpoints in cancer immunotherapy.
Nature reviews. Cancer
, 12
(4)
, 252-264.
https://doi.org/10.1038/nrc3239
Identifiers
- DOI
- 10.1038/nrc3239